elon musk before and after semaglutide GLP-1 based drugs: Could Musk's weight loss weapon help us, too? Novo Nordisk's Wegovy gets a

In clinical trials, discontinuation due to gastrointestinal side effects occurred in approximately 5% of patients receiving Wegovy compared to 1% with placebo (as reported in the SmPC)

Treppendahl, M.D., Ph.D., et al., for the STEP-HFpEF Trial Committees and Investigators* All articles and product information on this website are for educational purposes only

Semaglutide also has warnings for pancreatitis, diabetic retinopathy complications, hypoglycemia that can be severe, acute kidney injury, acute gallbladder disease, hypersensitivity reactions, and pulmonary aspiration during general anesthesia or deep sedation

Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP-3 randomized clinical trial

Adverse reactions to drugs BNF (NICE)